Sangamo Therapeutics Inc (NASDAQ:SGMO)

Delayed Data
As of Dec 02
 +0.08 / +2.25%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 11.00, with a high estimate of 25.00 and a low estimate of 4.00. The median estimate represents a +202.20% increase from the last price of 3.64.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.68%
Growthannually -5.54%


Growthquarterly 1.50%
Growthannually 0.03%
Key to the earnings and sales forecast charts.